{"transactions":[{"id":1517609,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:36:35.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":1341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4."},{"field":"date","element":"transactionDate","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date."}],"balance_after":1341,"derivative":{"exercise_price":8.21,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":1341},"source":{"system":"sec-edgar","filing":"0001062993-24-010189","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000106299324010189/form4a.xml","form_type":"4/A","original_submission_date":"2024-03-22"}},{"id":1563434,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T16:32:38.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":1341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date."}],"balance_after":1341,"derivative":{"exercise_price":8.32,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":1341},"source":{"system":"sec-edgar","filing":"0001062993-24-006959","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000106299324006959/form4.xml","form_type":"4"}},{"id":1932545,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:33:20.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date."}],"balance_after":40000,"derivative":{"exercise_price":0.3995,"expiration_date":"2033-03-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001062993-23-008322","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000106299323008322/form4.xml","form_type":"4"}},{"id":2308476,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:37:31.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date."}],"balance_after":20000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001062993-22-009451","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000106299322009451/form4.xml","form_type":"4"}},{"id":2761537,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T16:25:37.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date."}],"balance_after":10000,"derivative":{"exercise_price":2.93,"expiration_date":"2031-04-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000891839-21-000098","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000089183921000098/edgar.xml","form_type":"4"}},{"id":3246533,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-26T16:24:29.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date."}],"balance_after":8000,"derivative":{"exercise_price":6.07,"expiration_date":"2030-02-24","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000891839-20-000052","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000089183920000052/edgar.xml","form_type":"4"}},{"id":3587306,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91076,"kind":"person","name":"Smith Ernest S.","position":1,"cik":"0001747769","reported_name":"Smith Ernest S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-19T17:04:20.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date."}],"balance_after":8000,"derivative":{"exercise_price":3.9,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000891839-19-000049","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1747769/000089183919000049/edgar.xml","form_type":"4"}}]}